Analysis of serum antibody profile against H pylori VacA and CagA antigens in Turkish patients with duodenal ulcer
- PMID: 17106939
- PMCID: PMC4087445
- DOI: 10.3748/wjg.v12.i42.6869
Analysis of serum antibody profile against H pylori VacA and CagA antigens in Turkish patients with duodenal ulcer
Abstract
Aim: To investigate the frequency of seropositivity against CagA, VacA proteins and to determine their independent effects on the development of duodenal ulcer (DU) in Turkish patients.
Methods: The study was designed as a prospective one from a tertiary referral hospital. Dyspeptic patients who were referred to our endoscopy unit for upper gastrointestinal endoscopy between June 2003 and March 2004 and diagnosed to have DU or nonulcer dyspepsia (NUD) were included. Biopsies from the antrum and body of the stomach were taken in order to assess the current H pylori status by histology, rapid urease test and culture. Fasting sera were obtained from all patients and H pylori status of all sera was determined by IgG antibodies using an enzyme-linked immunosorbent assay (ELISA) kit. All seropositive patients were further analysed using Western blot assays detecting IgG antibodies against CagA and VacA proteins. The c2 test was used for statistical comparison of the values and age-sex adjusted multiple regression analysis was used to determine the independent effects of CagA and VacA seropositivities on the development of DU.
Results: Sixty-three patients with DU and 62 patients with NUD were eligible for the final analysis. Seropositivity for anti-CagA was detected in 51 of 62 (82%), and in 55 of 63 (87%) patients with NUD and DU, respectively (P = no significance), and seropositivity for anti-VacA was found in 25 of 62 (40% ) and in 16 of 63 (25%) patients, with NUD and DU, respectively.
Conclusion: These findings suggest that none of these virulence factors is associated with the development of DU in the studied Turkish patients with dyspepsia.
Similar articles
-
Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2 genotypes and correlation with clinical outcome in Turkish patients with dyspepsia.Helicobacter. 2006 Dec;11(6):574-80. doi: 10.1111/j.1523-5378.2006.00461.x. Helicobacter. 2006. PMID: 17083380
-
CagA status in dyspeptic patients with and without peptic ulcer disease in Turkey: association with histopathologic findings.Helicobacter. 2001 Jun;6(2):163-8. doi: 10.1046/j.1523-5378.2001.00024.x. Helicobacter. 2001. PMID: 11422473
-
Frequencies of serum antibodies to Helicobacter pylori CagA and VacA in a Turkish population with various gastroduodenal diseases.Int J Clin Pract. 2006 Oct;60(10):1239-43. doi: 10.1111/j.1742-1241.2005.00778.x. Epub 2006 Mar 27. Int J Clin Pract. 2006. PMID: 16669834
-
CagA and VacA: virulence factors of Helicobacter pylori in Thai patients with gastroduodenal diseases.Helicobacter. 1999 Sep;4(3):143-7. doi: 10.1046/j.1523-5378.1999.99305.x. Helicobacter. 1999. PMID: 10469187
-
Anti-CagA and anti-VacA antibodies in Helicobacter pylori-infected patients with and without peptic ulcer disease in Serbia and Montenegro.Scand J Gastroenterol. 2004 Mar;39(3):222-6. doi: 10.1080/00365520310008403. Scand J Gastroenterol. 2004. PMID: 15074390
Cited by
-
A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.World J Gastroenterol. 2014 Feb 14;20(6):1438-49. doi: 10.3748/wjg.v20.i6.1438. World J Gastroenterol. 2014. PMID: 24587620 Free PMC article. Review.
-
Rapid identification of Helicobacter pylori and assessment of clarithromycin susceptibility from clinical specimens using FISH.J Pathol Clin Res. 2016 Nov 26;3(1):29-37. doi: 10.1002/cjp2.57. eCollection 2017 Jan. J Pathol Clin Res. 2016. PMID: 28138399 Free PMC article.
-
cagA and vacA status and influence of Helicobacter pylori infection on serum oxidative DNA damage in Iranian patients with peptic ulcer disease.Ir J Med Sci. 2011 Mar;180(1):155-61. doi: 10.1007/s11845-010-0548-5. Epub 2010 Aug 20. Ir J Med Sci. 2011. PMID: 20721697
-
The significance of E266K polymorphism in the NOD1 gene on Helicobacter pylori infection: an effective force on pathogenesis?Clin Exp Med. 2010 Jun;10(2):107-12. doi: 10.1007/s10238-009-0077-6. Epub 2009 Oct 31. Clin Exp Med. 2010. PMID: 19882212
References
-
- Schistosomes , liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241. - PubMed
-
- Blaser MJ. Role of vacA and the cagA locus of Helicobacter pylori in human disease. Aliment Pharmacol Ther. 1996;10 Suppl 1:73–77. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous